Jazz Pharmaceuticals, Inc. (United States)

Jazz Pharmaceuticals is a global biopharmaceutical company focused on sleep disorders, oncology, and rare diseases. Key products include Xywav and Xyrem (sodium oxybate) for narcolepsy, Epidiolex (cannabidiol) for epilepsy syndromes, and Rylaze for acute lymphoblastic leukemia. Jazz’s specialty portfolio addresses serious conditions including excessive daytime sleepiness, cataplexy, and rare pediatric seizure disorders.